#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Antibiotics are medicines that fight bacterial infections .
3-1	17-28	Antibiotics	abstract	new	coref	3-3
3-2	29-32	are	_	_	_	_
3-3	33-42	medicines	substance	giv	coref	7-47
3-4	43-47	that	_	_	_	_
3-5	48-53	fight	_	_	_	_
3-6	54-63	bacterial	abstract[5]	new[5]	ana	4-1[0_5]
3-7	64-74	infections	abstract[5]	new[5]	_	_
3-8	75-76	.	_	_	_	_

#Text=They can save lives if they are used correctly , but nowadays antibiotic resistance has become a real problem .
4-1	77-81	They	abstract	giv	ana	4-6
4-2	82-85	can	_	_	_	_
4-3	86-90	save	_	_	_	_
4-4	91-96	lives	abstract	new	_	_
4-5	97-99	if	_	_	_	_
4-6	100-104	they	abstract	giv	coref	5-1[11_0]
4-7	105-108	are	_	_	_	_
4-8	109-113	used	_	_	_	_
4-9	114-123	correctly	_	_	_	_
4-10	124-125	,	_	_	_	_
4-11	126-129	but	_	_	_	_
4-12	130-138	nowadays	abstract[10]	new[10]	coref	7-4[27_10]
4-13	139-149	antibiotic	substance|abstract[10]	new|new[10]	coref	7-4
4-14	150-160	resistance	abstract[10]	new[10]	_	_
4-15	161-164	has	_	_	_	_
4-16	165-171	become	_	_	_	_
4-17	172-173	a	_	_	_	_
4-18	174-178	real	_	_	_	_
4-19	179-186	problem	_	_	_	_
4-20	187-188	.	_	_	_	_

#Text=Infections by resistant microorganisms do not respond to treatment , so the duration of the disease is prolonged , and the risk of death increases .
5-1	189-199	Infections	abstract[11]	giv[11]	_	_
5-2	200-202	by	abstract[11]	giv[11]	_	_
5-3	203-212	resistant	abstract[11]|animal[12]	giv[11]|new[12]	coref	6-28[23_12]
5-4	213-227	microorganisms	abstract[11]|animal[12]	giv[11]|new[12]	_	_
5-5	228-230	do	_	_	_	_
5-6	231-234	not	_	_	_	_
5-7	235-242	respond	_	_	_	_
5-8	243-245	to	_	_	_	_
5-9	246-255	treatment	event	new	coref	6-4[18_0]
5-10	256-257	,	_	_	_	_
5-11	258-260	so	_	_	_	_
5-12	261-264	the	time[14]	new[14]	_	_
5-13	265-273	duration	time[14]	new[14]	_	_
5-14	274-276	of	time[14]	new[14]	_	_
5-15	277-280	the	time[14]|abstract[15]	new[14]|new[15]	_	_
5-16	281-288	disease	time[14]|abstract[15]	new[14]|new[15]	_	_
5-17	289-291	is	_	_	_	_
5-18	292-301	prolonged	_	_	_	_
5-19	302-303	,	_	_	_	_
5-20	304-307	and	_	_	_	_
5-21	308-311	the	abstract[16]	new[16]	_	_
5-22	312-316	risk	abstract[16]	new[16]	_	_
5-23	317-319	of	abstract[16]	new[16]	_	_
5-24	320-325	death	abstract[16]|event	new[16]|new	_	_
5-25	326-335	increases	_	_	_	_
5-26	336-337	.	_	_	_	_

#Text=Moreover , if the treatment fails or if the response to treatment is slow , the patient is contagious for longer , which increases the likelihood of resistant microorganisms being transmitted to other people .
6-1	338-346	Moreover	_	_	_	_
6-2	347-348	,	_	_	_	_
6-3	349-351	if	_	_	_	_
6-4	352-355	the	event[18]	giv[18]	coref	6-12[0_18]
6-5	356-365	treatment	event[18]	giv[18]	_	_
6-6	366-371	fails	_	_	_	_
6-7	372-374	or	_	_	_	_
6-8	375-377	if	_	_	_	_
6-9	378-381	the	abstract[19]	new[19]	_	_
6-10	382-390	response	abstract[19]	new[19]	_	_
6-11	391-393	to	abstract[19]	new[19]	_	_
6-12	394-403	treatment	abstract[19]|event	new[19]|giv	_	_
6-13	404-406	is	_	_	_	_
6-14	407-411	slow	_	_	_	_
6-15	412-413	,	_	_	_	_
6-16	414-417	the	person[21]	new[21]	coref	10-37[76_21]
6-17	418-425	patient	person[21]	new[21]	_	_
6-18	426-428	is	_	_	_	_
6-19	429-439	contagious	_	_	_	_
6-20	440-443	for	_	_	_	_
6-21	444-450	longer	_	_	_	_
6-22	451-452	,	_	_	_	_
6-23	453-458	which	_	_	_	_
6-24	459-468	increases	_	_	_	_
6-25	469-472	the	abstract[22]	new[22]	_	_
6-26	473-483	likelihood	abstract[22]	new[22]	_	_
6-27	484-486	of	abstract[22]	new[22]	_	_
6-28	487-496	resistant	abstract[22]|substance[23]	new[22]|giv[23]	_	_
6-29	497-511	microorganisms	abstract[22]|substance[23]	new[22]|giv[23]	_	_
6-30	512-517	being	_	_	_	_
6-31	518-529	transmitted	_	_	_	_
6-32	530-532	to	_	_	_	_
6-33	533-538	other	person[24]	new[24]	_	_
6-34	539-545	people	person[24]	new[24]	_	_
6-35	546-547	.	_	_	_	_

#Text=The emergence of antibiotic resistance is a natural biological phenomenon , and even though numerous factors have been identified as the cause of this , such as clustering and overcrowding or increased elderly population , one of the most important factors is the inadequate use of antibiotics , a very worrying situation especially for healthcare professionals with high rate of antibiotic prescription such as primary care dentists .
7-1	548-551	The	abstract[25]	new[25]	coref	7-7[28_25]
7-2	552-561	emergence	abstract[25]	new[25]	_	_
7-3	562-564	of	abstract[25]	new[25]	_	_
7-4	565-575	antibiotic	abstract[25]|substance|abstract[27]	new[25]|giv|giv[27]	coref|coref|coref|coref	7-61|12-19[101_27]|7-61|12-19[101_27]
7-5	576-586	resistance	abstract[25]|abstract[27]	new[25]|giv[27]	_	_
7-6	587-589	is	_	_	_	_
7-7	590-591	a	abstract[28]	giv[28]	_	_
7-8	592-599	natural	abstract[28]	giv[28]	_	_
7-9	600-610	biological	abstract[28]	giv[28]	_	_
7-10	611-621	phenomenon	abstract[28]	giv[28]	_	_
7-11	622-623	,	_	_	_	_
7-12	624-627	and	_	_	_	_
7-13	628-632	even	_	_	_	_
7-14	633-639	though	_	_	_	_
7-15	640-648	numerous	abstract[29]	new[29]	coref	7-38[33_29]
7-16	649-656	factors	abstract[29]	new[29]	_	_
7-17	657-661	have	_	_	_	_
7-18	662-666	been	_	_	_	_
7-19	667-677	identified	_	_	_	_
7-20	678-680	as	_	_	_	_
7-21	681-684	the	_	_	_	_
7-22	685-690	cause	_	_	_	_
7-23	691-693	of	_	_	_	_
7-24	694-698	this	_	_	_	_
7-25	699-700	,	_	_	_	_
7-26	701-705	such	_	_	_	_
7-27	706-708	as	_	_	_	_
7-28	709-719	clustering	abstract	new	_	_
7-29	720-723	and	_	_	_	_
7-30	724-736	overcrowding	_	_	_	_
7-31	737-739	or	_	_	_	_
7-32	740-749	increased	abstract[31]	new[31]	_	_
7-33	750-757	elderly	abstract[31]	new[31]	_	_
7-34	758-768	population	abstract[31]	new[31]	_	_
7-35	769-770	,	_	_	_	_
7-36	771-774	one	abstract[32]	new[32]	coref	7-43[34_32]
7-37	775-777	of	abstract[32]	new[32]	_	_
7-38	778-781	the	abstract[32]|abstract[33]	new[32]|giv[33]	_	_
7-39	782-786	most	abstract[32]|abstract[33]	new[32]|giv[33]	_	_
7-40	787-796	important	abstract[32]|abstract[33]	new[32]|giv[33]	_	_
7-41	797-804	factors	abstract[32]|abstract[33]	new[32]|giv[33]	_	_
7-42	805-807	is	_	_	_	_
7-43	808-811	the	abstract[34]	giv[34]	coref	10-1[66_34]
7-44	812-822	inadequate	abstract[34]	giv[34]	_	_
7-45	823-826	use	abstract[34]	giv[34]	_	_
7-46	827-829	of	abstract[34]	giv[34]	_	_
7-47	830-841	antibiotics	abstract[34]|object	giv[34]|giv	coref	8-14
7-48	842-843	,	_	_	_	_
7-49	844-845	a	abstract[36]	new[36]	_	_
7-50	846-850	very	abstract[36]	new[36]	_	_
7-51	851-859	worrying	abstract[36]	new[36]	_	_
7-52	860-869	situation	abstract[36]	new[36]	_	_
7-53	870-880	especially	abstract[36]|person[38]	new[36]|new[38]	_	_
7-54	881-884	for	abstract[36]|person[38]	new[36]|new[38]	_	_
7-55	885-895	healthcare	abstract[36]|organization|person[38]	new[36]|new|new[38]	coref	10-34
7-56	896-909	professionals	abstract[36]|person[38]	new[36]|new[38]	_	_
7-57	910-914	with	abstract[36]|person[38]	new[36]|new[38]	_	_
7-58	915-919	high	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
7-59	920-924	rate	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
7-60	925-927	of	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
7-61	928-938	antibiotic	abstract[36]|person[38]|abstract[39]|substance|abstract[41]	new[36]|new[38]|new[39]|giv|new[41]	coref|coref|coref|coref	8-16[47_41]|13-10|8-16[47_41]|13-10
7-62	939-951	prescription	abstract[36]|person[38]|abstract[39]|abstract[41]	new[36]|new[38]|new[39]|new[41]	_	_
7-63	952-956	such	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
7-64	957-959	as	abstract[36]|person[38]|abstract[39]	new[36]|new[38]|new[39]	_	_
7-65	960-967	primary	abstract[36]|person[38]|abstract[39]|person[43]	new[36]|new[38]|new[39]|new[43]	_	_
7-66	968-972	care	abstract[36]|person[38]|abstract[39]|abstract|person[43]	new[36]|new[38]|new[39]|new|new[43]	_	_
7-67	973-981	dentists	abstract[36]|person[38]|abstract[39]|person[43]	new[36]|new[38]|new[39]|new[43]	_	_
7-68	982-983	.	_	_	_	_

#Text=According to the World Health Organization ( WHO ) , inadequate use of antibiotics includes the prescription of inappropriate antibiotics for a brief time , in low or insufficient doses and/or for diseases for which they are not indicated ; likewise , excessive therapeutic dosage regimens are also considered inadequate uses of antibiotics .
8-1	984-993	According	_	_	_	_
8-2	994-996	to	_	_	_	_
8-3	997-1000	the	organization[44]	new[44]	_	_
8-4	1001-1006	World	organization[44]	new[44]	_	_
8-5	1007-1013	Health	organization[44]	new[44]	_	_
8-6	1014-1026	Organization	organization[44]	new[44]	_	_
8-7	1027-1028	(	_	_	_	_
8-8	1029-1032	WHO	_	_	_	_
8-9	1033-1034	)	_	_	_	_
8-10	1035-1036	,	_	_	_	_
8-11	1037-1047	inadequate	abstract[45]	new[45]	_	_
8-12	1048-1051	use	abstract[45]	new[45]	_	_
8-13	1052-1054	of	abstract[45]	new[45]	_	_
8-14	1055-1066	antibiotics	abstract[45]|substance	new[45]|giv	coref	8-19[48_0]
8-15	1067-1075	includes	_	_	_	_
8-16	1076-1079	the	abstract[47]	giv[47]	coref	9-23[65_47]
8-17	1080-1092	prescription	abstract[47]	giv[47]	_	_
8-18	1093-1095	of	abstract[47]	giv[47]	_	_
8-19	1096-1109	inappropriate	abstract[47]|object[48]	giv[47]|giv[48]	coref	8-53[0_48]
8-20	1110-1121	antibiotics	abstract[47]|object[48]	giv[47]|giv[48]	_	_
8-21	1122-1125	for	abstract[47]|object[48]	giv[47]|giv[48]	_	_
8-22	1126-1127	a	abstract[47]|object[48]|time[49]	giv[47]|giv[48]|new[49]	_	_
8-23	1128-1133	brief	abstract[47]|object[48]|time[49]	giv[47]|giv[48]|new[49]	_	_
8-24	1134-1138	time	abstract[47]|object[48]|time[49]	giv[47]|giv[48]|new[49]	_	_
8-25	1139-1140	,	_	_	_	_
8-26	1141-1143	in	_	_	_	_
8-27	1144-1147	low	quantity[50]	new[50]	_	_
8-28	1148-1150	or	quantity[50]	new[50]	_	_
8-29	1151-1163	insufficient	quantity[50]	new[50]	_	_
8-30	1164-1169	doses	quantity[50]	new[50]	_	_
8-31	1170-1176	and/or	quantity[50]	new[50]	_	_
8-32	1177-1180	for	quantity[50]	new[50]	_	_
8-33	1181-1189	diseases	quantity[50]|abstract	new[50]|new	ana	8-36
8-34	1190-1193	for	_	_	_	_
8-35	1194-1199	which	_	_	_	_
8-36	1200-1204	they	abstract	giv	coref	12-16[100_0]
8-37	1205-1208	are	_	_	_	_
8-38	1209-1212	not	_	_	_	_
8-39	1213-1222	indicated	_	_	_	_
8-40	1223-1224	;	_	_	_	_
8-41	1225-1233	likewise	_	_	_	_
8-42	1234-1235	,	_	_	_	_
8-43	1236-1245	excessive	abstract[54]	new[54]	_	_
8-44	1246-1257	therapeutic	abstract[54]	new[54]	_	_
8-45	1258-1264	dosage	abstract|abstract[54]	new|new[54]	_	_
8-46	1265-1273	regimens	abstract[54]	new[54]	_	_
8-47	1274-1277	are	_	_	_	_
8-48	1278-1282	also	_	_	_	_
8-49	1283-1293	considered	_	_	_	_
8-50	1294-1304	inadequate	abstract[55]	new[55]	_	_
8-51	1305-1309	uses	abstract[55]	new[55]	_	_
8-52	1310-1312	of	abstract[55]	new[55]	_	_
8-53	1313-1324	antibiotics	abstract[55]|object	new[55]|giv	coref	9-11[60_0]
8-54	1325-1326	.	_	_	_	_

#Text=In the specific case of Spain , the consumption of antibiotics for outpatients is above the European average , and in hospitals their prescription is increasing .
9-1	1327-1329	In	_	_	_	_
9-2	1330-1333	the	abstract[57]	new[57]	_	_
9-3	1334-1342	specific	abstract[57]	new[57]	_	_
9-4	1343-1347	case	abstract[57]	new[57]	_	_
9-5	1348-1350	of	abstract[57]	new[57]	_	_
9-6	1351-1356	Spain	abstract[57]|place	new[57]|new	coref	13-43[122_0]
9-7	1357-1358	,	_	_	_	_
9-8	1359-1362	the	abstract[59]	new[59]	_	_
9-9	1363-1374	consumption	abstract[59]	new[59]	_	_
9-10	1375-1377	of	abstract[59]	new[59]	_	_
9-11	1378-1389	antibiotics	abstract[59]|object[60]	new[59]|giv[60]	coref	10-5[0_60]
9-12	1390-1393	for	abstract[59]|object[60]	new[59]|giv[60]	_	_
9-13	1394-1405	outpatients	abstract[59]|object[60]|person	new[59]|giv[60]|new	ana	9-23
9-14	1406-1408	is	_	_	_	_
9-15	1409-1414	above	_	_	_	_
9-16	1415-1418	the	abstract[62]	new[62]	_	_
9-17	1419-1427	European	abstract[62]	new[62]	_	_
9-18	1428-1435	average	abstract[62]	new[62]	_	_
9-19	1436-1437	,	_	_	_	_
9-20	1438-1441	and	_	_	_	_
9-21	1442-1444	in	_	_	_	_
9-22	1445-1454	hospitals	place	new	_	_
9-23	1455-1460	their	person|abstract[65]	giv|giv[65]	_	_
9-24	1461-1473	prescription	abstract[65]	giv[65]	_	_
9-25	1474-1476	is	_	_	_	_
9-26	1477-1487	increasing	_	_	_	_
9-27	1488-1489	.	_	_	_	_

#Text=The inadequate use of antibiotics can be encouraged by self-medication , by the implementation of permissive policies in terms of regulation of the use of these drugs , by the relationship between the healthcare professional and the patient or by the knowledge and attitudes that one has towards them .
10-1	1490-1493	The	abstract[66]	giv[66]	_	_
10-2	1494-1504	inadequate	abstract[66]	giv[66]	_	_
10-3	1505-1508	use	abstract[66]	giv[66]	_	_
10-4	1509-1511	of	abstract[66]	giv[66]	_	_
10-5	1512-1523	antibiotics	abstract[66]|object	giv[66]|giv	coref	10-26[73_0]
10-6	1524-1527	can	_	_	_	_
10-7	1528-1530	be	_	_	_	_
10-8	1531-1541	encouraged	_	_	_	_
10-9	1542-1544	by	_	_	_	_
10-10	1545-1560	self-medication	abstract	new	_	_
10-11	1561-1562	,	_	_	_	_
10-12	1563-1565	by	_	_	_	_
10-13	1566-1569	the	abstract[69]	new[69]	_	_
10-14	1570-1584	implementation	abstract[69]	new[69]	_	_
10-15	1585-1587	of	abstract[69]	new[69]	_	_
10-16	1588-1598	permissive	abstract[69]|abstract[70]	new[69]|new[70]	_	_
10-17	1599-1607	policies	abstract[69]|abstract[70]	new[69]|new[70]	_	_
10-18	1608-1610	in	abstract[69]|abstract[70]	new[69]|new[70]	_	_
10-19	1611-1616	terms	abstract[69]|abstract[70]	new[69]|new[70]	_	_
10-20	1617-1619	of	abstract[69]|abstract[70]	new[69]|new[70]	_	_
10-21	1620-1630	regulation	abstract[69]|abstract[70]|abstract[71]	new[69]|new[70]|new[71]	_	_
10-22	1631-1633	of	abstract[69]|abstract[70]|abstract[71]	new[69]|new[70]|new[71]	_	_
10-23	1634-1637	the	abstract[69]|abstract[70]|abstract[71]|abstract[72]	new[69]|new[70]|new[71]|new[72]	_	_
10-24	1638-1641	use	abstract[69]|abstract[70]|abstract[71]|abstract[72]	new[69]|new[70]|new[71]|new[72]	_	_
10-25	1642-1644	of	abstract[69]|abstract[70]|abstract[71]|abstract[72]	new[69]|new[70]|new[71]|new[72]	_	_
10-26	1645-1650	these	abstract[69]|abstract[70]|abstract[71]|abstract[72]|substance[73]	new[69]|new[70]|new[71]|new[72]|giv[73]	coref	11-17[0_73]
10-27	1651-1656	drugs	abstract[69]|abstract[70]|abstract[71]|abstract[72]|substance[73]	new[69]|new[70]|new[71]|new[72]|giv[73]	_	_
10-28	1657-1658	,	_	_	_	_
10-29	1659-1661	by	_	_	_	_
10-30	1662-1665	the	abstract[74]	new[74]	_	_
10-31	1666-1678	relationship	abstract[74]	new[74]	_	_
10-32	1679-1686	between	abstract[74]	new[74]	_	_
10-33	1687-1690	the	abstract[74]	new[74]	_	_
10-34	1691-1701	healthcare	abstract[74]|organization	new[74]|giv	coref	12-12
10-35	1702-1714	professional	abstract[74]	new[74]	_	_
10-36	1715-1718	and	abstract[74]	new[74]	_	_
10-37	1719-1722	the	abstract[74]|person[76]	new[74]|giv[76]	_	_
10-38	1723-1730	patient	abstract[74]|person[76]	new[74]|giv[76]	_	_
10-39	1731-1733	or	abstract[74]	new[74]	_	_
10-40	1734-1736	by	abstract[74]	new[74]	_	_
10-41	1737-1740	the	abstract[74]|abstract[77]|abstract[78]	new[74]|new[77]|new[78]	ana|coref|ana|coref	10-49[0_78]|11-10[83_77]|10-49[0_78]|11-10[83_77]
10-42	1741-1750	knowledge	abstract[74]|abstract[77]|abstract[78]	new[74]|new[77]|new[78]	_	_
10-43	1751-1754	and	abstract[74]|abstract[78]	new[74]|new[78]	_	_
10-44	1755-1764	attitudes	abstract[74]|abstract[78]|abstract	new[74]|new[78]|new	_	_
10-45	1765-1769	that	_	_	_	_
10-46	1770-1773	one	person	new	_	_
10-47	1774-1777	has	_	_	_	_
10-48	1778-1785	towards	_	_	_	_
10-49	1786-1790	them	abstract	giv	coref	11-10[84_0]
10-50	1791-1792	.	_	_	_	_

#Text=Regarding the latter , while it is true that a poor knowledge or negative attitude towards antibiotics leads inevitably to bad clinical practice , practical skills are not always a reflection of knowledge , a situation known as “ theory – practice gap ” .
11-1	1793-1802	Regarding	_	_	_	_
11-2	1803-1806	the	_	_	_	_
11-3	1807-1813	latter	_	_	_	_
11-4	1814-1815	,	_	_	_	_
11-5	1816-1821	while	_	_	_	_
11-6	1822-1824	it	abstract	new	cata	11-6[0_87]
11-7	1825-1827	is	_	_	_	_
11-8	1828-1832	true	_	_	_	_
11-9	1833-1837	that	abstract[87]	new[87]	_	_
11-10	1838-1839	a	abstract[83]|abstract[84]|abstract[87]	giv[83]|giv[84]|new[87]	coref|coref|coref|coref	11-33[0_83]|14-12[133_84]|11-33[0_83]|14-12[133_84]
11-11	1840-1844	poor	abstract[83]|abstract[84]|abstract[87]	giv[83]|giv[84]|new[87]	_	_
11-12	1845-1854	knowledge	abstract[83]|abstract[84]|abstract[87]	giv[83]|giv[84]|new[87]	_	_
11-13	1855-1857	or	abstract[84]|abstract[87]	giv[84]|new[87]	_	_
11-14	1858-1866	negative	abstract[84]|abstract[85]|abstract[87]	giv[84]|new[85]|new[87]	_	_
11-15	1867-1875	attitude	abstract[84]|abstract[85]|abstract[87]	giv[84]|new[85]|new[87]	_	_
11-16	1876-1883	towards	abstract[84]|abstract[85]|abstract[87]	giv[84]|new[85]|new[87]	_	_
11-17	1884-1895	antibiotics	abstract[84]|abstract[85]|object|abstract[87]	giv[84]|new[85]|giv|new[87]	coref	12-25
11-18	1896-1901	leads	abstract[87]	new[87]	_	_
11-19	1902-1912	inevitably	abstract[87]	new[87]	_	_
11-20	1913-1915	to	_	_	_	_
11-21	1916-1919	bad	abstract[88]	new[88]	coref	11-42[0_88]
11-22	1920-1928	clinical	abstract[88]	new[88]	_	_
11-23	1929-1937	practice	abstract[88]	new[88]	_	_
11-24	1938-1939	,	_	_	_	_
11-25	1940-1949	practical	abstract[89]	new[89]	_	_
11-26	1950-1956	skills	abstract[89]	new[89]	_	_
11-27	1957-1960	are	_	_	_	_
11-28	1961-1964	not	_	_	_	_
11-29	1965-1971	always	object[90]	new[90]	_	_
11-30	1972-1973	a	object[90]	new[90]	_	_
11-31	1974-1984	reflection	object[90]	new[90]	_	_
11-32	1985-1987	of	object[90]	new[90]	_	_
11-33	1988-1997	knowledge	object[90]|abstract	new[90]|giv	appos	11-35[92_0]
11-34	1998-1999	,	_	_	_	_
11-35	2000-2001	a	abstract[92]	giv[92]	coref	14-12[132_92]
11-36	2002-2011	situation	abstract[92]	giv[92]	_	_
11-37	2012-2017	known	_	_	_	_
11-38	2018-2020	as	_	_	_	_
11-39	2021-2022	“	_	_	_	_
11-40	2023-2029	theory	_	_	_	_
11-41	2030-2031	–	_	_	_	_
11-42	2032-2040	practice	abstract|abstract[94]	giv|new[94]	_	_
11-43	2041-2044	gap	abstract[94]	new[94]	_	_
11-44	2045-2046	”	_	_	_	_
11-45	2047-2048	.	_	_	_	_

#Text=To date , the studies which have evaluated the training that healthcare students have about infectious diseases , antimicrobial resistance and safe use of antibiotics have been mainly carried out in students of medicine and pharmacy , besides students from other disciplines such as dentistry .
12-1	2049-2051	To	_	_	_	_
12-2	2052-2056	date	time	new	_	_
12-3	2057-2058	,	_	_	_	_
12-4	2059-2062	the	abstract[96]	new[96]	_	_
12-5	2063-2070	studies	abstract[96]	new[96]	_	_
12-6	2071-2076	which	_	_	_	_
12-7	2077-2081	have	_	_	_	_
12-8	2082-2091	evaluated	_	_	_	_
12-9	2092-2095	the	abstract[97]	new[97]	coref	13-46[123_97]
12-10	2096-2104	training	abstract[97]	new[97]	_	_
12-11	2105-2109	that	_	_	_	_
12-12	2110-2120	healthcare	abstract|person[99]	giv|new[99]	coref|coref	12-32[104_99]|12-32[104_99]
12-13	2121-2129	students	person[99]	new[99]	_	_
12-14	2130-2134	have	_	_	_	_
12-15	2135-2140	about	_	_	_	_
12-16	2141-2151	infectious	abstract[100]	giv[100]	_	_
12-17	2152-2160	diseases	abstract[100]	giv[100]	_	_
12-18	2161-2162	,	_	_	_	_
12-19	2163-2176	antimicrobial	abstract[101]	giv[101]	coref	13-10[113_101]
12-20	2177-2187	resistance	abstract[101]	giv[101]	_	_
12-21	2188-2191	and	_	_	_	_
12-22	2192-2196	safe	event[102]	new[102]	_	_
12-23	2197-2200	use	event[102]	new[102]	_	_
12-24	2201-2203	of	event[102]	new[102]	_	_
12-25	2204-2215	antibiotics	event[102]|object	new[102]|giv	coref	13-30
12-26	2216-2220	have	_	_	_	_
12-27	2221-2225	been	_	_	_	_
12-28	2226-2232	mainly	_	_	_	_
12-29	2233-2240	carried	_	_	_	_
12-30	2241-2244	out	_	_	_	_
12-31	2245-2247	in	_	_	_	_
12-32	2248-2256	students	person[104]	giv[104]	coref	12-39[0_104]
12-33	2257-2259	of	person[104]	giv[104]	_	_
12-34	2260-2268	medicine	person[104]|abstract	giv[104]|new	_	_
12-35	2269-2272	and	person[104]	giv[104]	_	_
12-36	2273-2281	pharmacy	person[104]|abstract	giv[104]|new	_	_
12-37	2282-2283	,	_	_	_	_
12-38	2284-2291	besides	_	_	_	_
12-39	2292-2300	students	person	giv	coref	14-13[131_0]
12-40	2301-2305	from	_	_	_	_
12-41	2306-2311	other	abstract[108]	new[108]	_	_
12-42	2312-2323	disciplines	abstract[108]	new[108]	_	_
12-43	2324-2328	such	abstract[108]	new[108]	_	_
12-44	2329-2331	as	abstract[108]	new[108]	_	_
12-45	2332-2341	dentistry	abstract[108]|abstract	new[108]|new	_	_
12-46	2342-2343	.	_	_	_	_

#Text=However , taking into account that the control of antibiotic resistance requires a multidisciplinary approach , and that nursing staff play a key role in the rational use of antibiotics , as teachers of patients , and as future drug prescribers in our country , the training of nurses could have an important impact in reducing the incidence of antibiotic resistance .
13-1	2344-2351	However	_	_	_	_
13-2	2352-2353	,	_	_	_	_
13-3	2354-2360	taking	_	_	_	_
13-4	2361-2365	into	_	_	_	_
13-5	2366-2373	account	abstract	new	_	_
13-6	2374-2378	that	_	_	_	_
13-7	2379-2382	the	abstract[111]	new[111]	_	_
13-8	2383-2390	control	abstract[111]	new[111]	_	_
13-9	2391-2393	of	abstract[111]	new[111]	_	_
13-10	2394-2404	antibiotic	abstract[111]|substance|abstract[113]	new[111]|giv|giv[113]	coref|coref|coref|coref	13-60|13-60[128_113]|13-60|13-60[128_113]
13-11	2405-2415	resistance	abstract[111]|abstract[113]	new[111]|giv[113]	_	_
13-12	2416-2424	requires	_	_	_	_
13-13	2425-2426	a	abstract[114]	new[114]	_	_
13-14	2427-2444	multidisciplinary	abstract[114]	new[114]	_	_
13-15	2445-2453	approach	abstract[114]	new[114]	_	_
13-16	2454-2455	,	_	_	_	_
13-17	2456-2459	and	_	_	_	_
13-18	2460-2464	that	_	_	_	_
13-19	2465-2472	nursing	person[115]	new[115]	_	_
13-20	2473-2478	staff	person[115]	new[115]	_	_
13-21	2479-2483	play	_	_	_	_
13-22	2484-2485	a	abstract[116]	new[116]	_	_
13-23	2486-2489	key	abstract[116]	new[116]	_	_
13-24	2490-2494	role	abstract[116]	new[116]	_	_
13-25	2495-2497	in	abstract[116]	new[116]	_	_
13-26	2498-2501	the	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-27	2502-2510	rational	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-28	2511-2514	use	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-29	2515-2517	of	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-30	2518-2529	antibiotics	abstract[116]|abstract[117]|object	new[116]|new[117]|giv	_	_
13-31	2530-2531	,	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-32	2532-2534	as	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-33	2535-2543	teachers	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-34	2544-2546	of	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-35	2547-2555	patients	abstract[116]|abstract[117]|person	new[116]|new[117]|new	_	_
13-36	2556-2557	,	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-37	2558-2561	and	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-38	2562-2564	as	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-39	2565-2571	future	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-40	2572-2576	drug	abstract[116]|abstract[117]|substance	new[116]|new[117]|new	_	_
13-41	2577-2588	prescribers	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-42	2589-2591	in	abstract[116]|abstract[117]	new[116]|new[117]	_	_
13-43	2592-2595	our	abstract[116]|abstract[117]|person|place[122]	new[116]|new[117]|acc|giv[122]	_	_
13-44	2596-2603	country	abstract[116]|abstract[117]|place[122]	new[116]|new[117]|giv[122]	_	_
13-45	2604-2605	,	_	_	_	_
13-46	2606-2609	the	abstract[123]	giv[123]	_	_
13-47	2610-2618	training	abstract[123]	giv[123]	_	_
13-48	2619-2621	of	abstract[123]	giv[123]	_	_
13-49	2622-2628	nurses	abstract[123]|person	giv[123]|new	_	_
13-50	2629-2634	could	_	_	_	_
13-51	2635-2639	have	_	_	_	_
13-52	2640-2642	an	abstract[125]	new[125]	_	_
13-53	2643-2652	important	abstract[125]	new[125]	_	_
13-54	2653-2659	impact	abstract[125]	new[125]	_	_
13-55	2660-2662	in	_	_	_	_
13-56	2663-2671	reducing	_	_	_	_
13-57	2672-2675	the	abstract[126]	new[126]	_	_
13-58	2676-2685	incidence	abstract[126]	new[126]	_	_
13-59	2686-2688	of	abstract[126]	new[126]	_	_
13-60	2689-2699	antibiotic	abstract[126]|substance|abstract[128]	new[126]|giv|giv[128]	coref|coref|coref|coref	14-20|14-23[0_128]|14-20|14-23[0_128]
13-61	2700-2710	resistance	abstract[126]|abstract[128]	new[126]|giv[128]	_	_
13-62	2711-2712	.	_	_	_	_

#Text=Thus , the objective of this paper has been to determine the nursing students ’ knowledge and awareness of antibiotic use , resistance and stewardship .
14-1	2713-2717	Thus	_	_	_	_
14-2	2718-2719	,	_	_	_	_
14-3	2720-2723	the	abstract[129]	new[129]	_	_
14-4	2724-2733	objective	abstract[129]	new[129]	_	_
14-5	2734-2736	of	abstract[129]	new[129]	_	_
14-6	2737-2741	this	abstract[129]|abstract[130]	new[129]|new[130]	_	_
14-7	2742-2747	paper	abstract[129]|abstract[130]	new[129]|new[130]	_	_
14-8	2748-2751	has	_	_	_	_
14-9	2752-2756	been	_	_	_	_
14-10	2757-2759	to	_	_	_	_
14-11	2760-2769	determine	_	_	_	_
14-12	2770-2773	the	abstract[132]|abstract[133]	giv[132]|giv[133]	_	_
14-13	2774-2781	nursing	person[131]|abstract[132]|abstract[133]	giv[131]|giv[132]|giv[133]	_	_
14-14	2782-2790	students	person[131]|abstract[132]|abstract[133]	giv[131]|giv[132]|giv[133]	_	_
14-15	2791-2792	’	person[131]|abstract[132]|abstract[133]	giv[131]|giv[132]|giv[133]	_	_
14-16	2793-2802	knowledge	abstract[132]|abstract[133]	giv[132]|giv[133]	_	_
14-17	2803-2806	and	abstract[133]	giv[133]	_	_
14-18	2807-2816	awareness	abstract[133]|abstract[134]	giv[133]|new[134]	_	_
14-19	2817-2819	of	abstract[133]|abstract[134]	giv[133]|new[134]	_	_
14-20	2820-2830	antibiotic	abstract[133]|abstract[134]|substance|abstract[136]	giv[133]|new[134]|giv|new[136]	_	_
14-21	2831-2834	use	abstract[133]|abstract[134]|abstract[136]	giv[133]|new[134]|new[136]	_	_
14-22	2835-2836	,	abstract[133]|abstract[134]	giv[133]|new[134]	_	_
14-23	2837-2847	resistance	abstract[133]|abstract[134]|abstract	giv[133]|new[134]|giv	_	_
14-24	2848-2851	and	abstract[133]|abstract[134]	giv[133]|new[134]	_	_
14-25	2852-2863	stewardship	abstract[133]|abstract[134]|abstract	giv[133]|new[134]|new	_	_
14-26	2864-2865	.	_	_	_	_
